RecruitingPhase 2NCT07466485

The Efficacy of Tocotrienol Rich Fraction for Liver Protection in Adult Patients With Alcoholic Fatty Liver Disease (AFLD)

Studying Rapidly involuting congenital hemangioma

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Universiti Kebangsaan Malaysia Medical Centre
Principal Investigator
Professor Dr. Nur Azlina Mohd Fahami, DVM
Department of Pharmacology, Faculty of Medicine, Universiti Kebangsaan Malaysia (UKM)
Intervention
Palm Tocotrienol Rich Fraction (TRF)(dietary_supplement)
Enrollment
26 target
Eligibility
18-65 years · All sexes
Timeline
20262026

Study locations (1)

Collaborators

Malaysia Palm Oil Board · Hovid Berhad

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT07466485 on ClinicalTrials.gov

Other trials for Rapidly involuting congenital hemangioma

Additional recruiting or active studies for the same condition.

See all trials for Rapidly involuting congenital hemangioma

← Back to all trials